17,465
Views
53
CrossRef citations to date
0
Altmetric
Commentary

Optimization of genome editing through CRISPR-Cas9 engineering

, , , &
Pages 166-174 | Received 13 Apr 2016, Accepted 09 May 2016, Published online: 24 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Francesca Becherucci, Benedetta Mazzinghi, Marco Allinovi, Maria Lucia Angelotti & Paola Romagnani. (2018) Regenerating the kidney using human pluripotent stem cells and renal progenitors. Expert Opinion on Biological Therapy 18:7, pages 795-806.
Read now
Fernando Perez Rojo, Rikard Karl Martin Nyman, Alexander Arthur Theodore Johnson, Maria Pazos Navarro, Megan Helen Ryan, William Erskine & Parwinder Kaur. (2018) CRISPR-Cas systems: ushering in the new genome editing era. Bioengineered 9:1, pages 214-221.
Read now

Articles from other publishers (51)

Chen Chen, Zehua Wang & Yanru Qin. (2023) CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy. Experimental Hematology & Oncology 12:1.
Crossref
Navid Dadashpour Davachi, Pawel M. Bartlewski, Reza Masoudi & Roozbeh Fallahi. (2023) Suitability of a universal electroporation device for genome editing and production of transgenic rats. Reproductive Biology 23:2, pages 100755.
Crossref
Shao Wei Hu, Tao Ding, Honghai Tang, Huiping Guo, Wenguo Cui & Yilai Shu. (2023) Nanobiomaterial vectors for improving gene editing and gene therapy. Materials Today 66, pages 114-136.
Crossref
Xifeng Hu, Xiangdong Wu, Zheng Chen & Huansheng Wu. (2023) Chicken PRMT1 promotes infectious bursal disease virus replication via suppressing IFN-β production. Developmental & Comparative Immunology 141, pages 104628.
Crossref
Muhammad Naeem & Omer S. Alkhnbashi. (2023) Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects. International Journal of Molecular Sciences 24:7, pages 6261.
Crossref
Bohan Wang, Xiunan Huo, Xianglei Zhang, Yuanhao Liang, Yingying Yang, Jiacheng Shi, Xinyu Huan, Xilin Hou, Weilin Lv & Yi Zhan. 2023. Synthetic Biology and iGEM: Techniques, Development and Safety Concerns. Synthetic Biology and iGEM: Techniques, Development and Safety Concerns 39 61 .
Paula Carrillo-Rodriguez, Javier Martinez-Lopez, Laura Gómez-Hernández, Luis Boraita-Morales, Maria Uceda-Molina, Irene Cuenca-Bermejo, Juan P. Valencia-Aguirre, Marahy Mora-López & Julio Plaza-Diaz. 2023. Genome Editing in Cardiovascular and Metabolic Diseases. Genome Editing in Cardiovascular and Metabolic Diseases 19 33 .
Parth Shah. 2023. Genome Editing in Cardiovascular and Metabolic Diseases. Genome Editing in Cardiovascular and Metabolic Diseases 207 214 .
Tingting Yang, Priyanka Gokulnath, Xinxiu Meng, Guoping Li & Junjie Xiao. 2023. Genome Editing in Cardiovascular and Metabolic Diseases. Genome Editing in Cardiovascular and Metabolic Diseases 157 176 .
Muhammad Khuram Razzaq, Muhammad Akhter, Ramala Masood Ahmad, Kaiser Latif Cheema, Aiman Hina, Benjamin Karikari, Ghulam Raza, Guangnan Xing, Junyi Gai & Mohsin Khurshid. (2022) CRISPR-Cas9 based stress tolerance: New hope for abiotic stress tolerance in chickpea (Cicer arietinum). Molecular Biology Reports 49:9, pages 8977-8985.
Crossref
Jasprina N. Noordermeer, Crystal Chen & Lei S. Qi. 2022. Crispr. Crispr 195 212 .
Sekhar Talluri. (2022) Engineering and Design of Programmable Genome Editors. The Journal of Physical Chemistry B 126:28, pages 5140-5150.
Crossref
Tong Gu, Zhenghu Tong, Xue Zhang, Zhiyong Wang, Zhen Zhang, Tzann-Shun Hwang & Lin Li. (2022) Carbon Metabolism of a Soilborne Mn(II)-Oxidizing Escherichia coli Isolate Implicated as a Pronounced Modulator of Bacterial Mn Oxidation. International Journal of Molecular Sciences 23:11, pages 5951.
Crossref
Anthony Matta, Vanessa Nader, Marine Lebrin, Fabian Gross, Anne-Catherine Prats, Daniel Cussac, Michel Galinier & Jerome Roncalli. (2022) Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease. Cells 11:10, pages 1620.
Crossref
Tunahan Ergünay, Özgecan Ayhan, Arda B Celen, Panagiota Georgiadou, Emre Pekbilir, Yusuf T Abaci, Duygu Yesildag, Mandy Rettel, Ulduz Sobhiafshar, Anna Ogmen, NC Tolga Emre & Umut Sahin. (2022) Sumoylation of Cas9 at lysine 848 regulates protein stability and DNA binding. Life Science Alliance 5:4, pages e202101078.
Crossref
Mina Roueinfar, Hayley N. Templeton, Julietta A. Sheng & Ka Lok Hong. (2022) An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology. Molecules 27:3, pages 1114.
Crossref
Maja van Hees, Sofie Slott, Anders Højgaard Hansen, Heon Seok Kim, Hanlee P. Ji & Kira Astakhova. (2022) New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape. Molecular Therapy 30:1, pages 32-46.
Crossref
Wanping Chen, Wenwen She, Aitao Li, Chao Zhai & Lixin Ma. 2022. Directed Evolution. Directed Evolution 165 174 .
Yanling Li, Zhipeng Jia, Shuchao Zhang & Xiaozhen He. (2021) Progress in Gene-Editing Technology of Zebrafish. Biomolecules 11:9, pages 1300.
Crossref
Bixi Sun, Hening Chen & Xiaoshu Gao. (2021) Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application. Journal of Controlled Release 337, pages 698-717.
Crossref
Trishit Banerjee, Hiroto Takahashi, Dwiky Rendra Graha Subekti & Kiyoto Kamagata. (2021) Engineering of the genome editing protein Cas9 to slide along DNA. Scientific Reports 11:1.
Crossref
Bidhan C. Dhar, Nathalie Steimberg & Giovanna Mazzoleni. (2021) Point‐of‐Care Pathogen Detection with CRISPR‐based Programmable Nucleic Acid Binding Proteins. ChemMedChem 16:10, pages 1566-1575.
Crossref
Munazza Ahmed, Grace Hope Daoud, Asmaa Mohamed & Rania Harati. (2021) New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer. Genes 12:5, pages 723.
Crossref
Roberto Piergentili, Alessandro Del Rio, Fabrizio Signore, Federica Umani Ronchi, Enrico Marinelli & Simona Zaami. (2021) CRISPR-Cas and Its Wide-Ranging Applications: From Human Genome Editing to Environmental Implications, Technical Limitations, Hazards and Bioethical Issues. Cells 10:5, pages 969.
Crossref
Travis J. Fleming, Catherine S. Schrankel, Himanshu Vyas, Hannah D. Rosenblatt & Amro Hamdoun. (2021) CRISPR/Cas9 mutagenesis reveals a role for ABCB1 in gut immune responses to Vibrio diazotrophicus in sea urchin larvae . Journal of Experimental Biology 224:7.
Crossref
Benjamin Klapholz, Heather Levy, Ramesh Kumbha, Nora Hosny, Michael E. D'Angelo, Bernhard J. Hering & Christopher Burlak. (2021) Highly efficient multiplex genetic engineering of porcine primary fetal fibroblasts. Surgery Open Science 4, pages 26-31.
Crossref
Sweta Nidhi, Uttpal Anand, Patrik Oleksak, Pooja Tripathi, Jonathan A. Lal, George Thomas, Kamil Kuca & Vijay Tripathi. (2021) Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives. International Journal of Molecular Sciences 22:7, pages 3327.
Crossref
Yiyi Yang & Xiaowen Cheng. 2021. The Intestine. The Intestine 75 86 .
Chaogang Wei, Tong Chen, Yueyue Zhang, Yanfeng Wang, Dai Shi, Zhen Jiang, Kai Li, Li Xiao & Junkang Shen. (2020) A Novel White-to-Blue Colony Formation Assay to Select for Optimized sgRNAs. Molecular Biotechnology 63:1, pages 1-12.
Crossref
Meng-Yuan Li, Yun-Tong Jiao, Yu-Ting Wang, Na Zhang, Bian-Bian Wang, Rui-Qi Liu, Xiao Yin, Yan Xu & Guo-Tian Liu. (2020) CRISPR/Cas9-mediated VvPR4b editing decreases downy mildew resistance in grapevine (Vitis vinifera L.). Horticulture Research 7:1.
Crossref
Fatima Akram, Ikram ul Haq, Zeeshan Ahmed, Hamza Khan & Muhammad Shrafat Ali. (2020) CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review. Protein & Peptide Letters 27:10, pages 931-944.
Crossref
Rebecca Leech & Karuna Sampath. (2020) A CRISPR cut for messenger RNAs. Lab Animal 49:11, pages 317-319.
Crossref
Mahmoud Nateghi Rostami. (2020) CRISPR/Cas9 gene drive technology to control transmission of vector‐borne parasitic infections. Parasite Immunology 42:9.
Crossref
Hui Wang, Hua Lu, Ying-shou Lei, Chen-yu Gong, Zhao Chen, Ying-qiao Luan, Qiang Li, Ying-zhen Jian, Hao-zheng Wang, Feng-lin Wu, Chang-li Tao, Han Shen, Hua-ben Bo, Hong-wei Shao & Wen-feng Zhang. (2020) Development of a Self-Restricting CRISPR-Cas9 System to Reduce Off-Target Effects. Molecular Therapy - Methods & Clinical Development 18, pages 390-401.
Crossref
Amir K. Varkouhi, Ana Paula Teixeira Monteiro, James N. Tsoporis, Shirley H. J. Mei, Duncan J. Stewart & Claudia C. dos Santos. (2020) Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness. Stem Cell Reviews and Reports.
Crossref
Miao Wu, Niandan Hu, Xianjin Du & Jie Wei. (2020) Application of CRISPR/Cas9 technology in sepsis research. Briefings in Functional Genomics 19:3, pages 229-234.
Crossref
Yongzhen Liu, Zengkun Xu, Yu Zhang, Mengmeng Yu, Suyan Wang, Yulong Gao, Changjun Liu, Yanping Zhang, Li Gao, Xiaole Qi, Hongyu Cui, Qing Pan, Kai Li & Xiaomei Wang. (2020) Marek’s disease virus as a CRISPR/Cas9 delivery system to defend against avian leukosis virus infection in chickens. Veterinary Microbiology 242, pages 108589.
Crossref
Ziyao FAN, Tianwen WU, Kui WU, Yulian MU & Kui LI. (2020) Reflections on the system of evaluation of gene-edited livestock. Frontiers of Agricultural Science and Engineering 7:2, pages 211.
Crossref
Mike Broeders, Pablo Herrero-Hernandez, Martijn P.T. Ernst, Ans T. van der Ploeg & W.W.M. Pim Pijnappel. (2020) Sharpening the Molecular Scissors: Advances in Gene-Editing Technology. iScience 23:1, pages 100789.
Crossref
Richa Salwan, Anu Sharma & Vivek Sharma. 2020. Physiological and Biotechnological Aspects of Extremophiles. Physiological and Biotechnological Aspects of Extremophiles 155 168 .
Safikur Rahman, Manali Datta, Jihoe Kim & Arif Tasleem Jan. (2019) CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases. Seminars in Cell & Developmental Biology 96, pages 22-31.
Crossref
Sikandar Hayat Khan. (2019) Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application. Molecular Therapy - Nucleic Acids 16, pages 326-334.
Crossref
Lianggang Huang, Hongzhi Dong, Junwei Zheng, Bin Wang & Li Pan. (2019) Highly efficient single base editing in Aspergillus niger with CRISPR/Cas9 cytidine deaminase fusion. Microbiological Research 223-225, pages 44-50.
Crossref
Viktor Limanskiy, Arpita Vyas, Lakshmi Shankar Chaturvedi & Dinesh Vyas. (2019) Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World Journal of Gastroenterology 25:18, pages 2177-2187.
Crossref
Tony M. PlantMichael Candlish, Philipp Wartenberg & Ulrich Boehm. 2018. The GnRH Neuron and its Control. The GnRH Neuron and its Control 259 287 .
Orietta Pansarasa, Matteo Bordoni, Luca Diamanti, Daisy Sproviero, Stella Gagliardi & Cristina Cereda. (2018) SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease. International Journal of Molecular Sciences 19:5, pages 1345.
Crossref
Makda Gebre, Jason Nomburg & Benjamin Gewurz. (2018) CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions. Viruses 10:2, pages 55.
Crossref
Stéphane Mathis & Gwendal Le Masson. (2018) RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis. Biomedicines 6:1, pages 9.
Crossref
Duy N. Do, Pier-Luc Dudemaine, Bridget Fomenky & Eveline M. Ibeagha-Awemu. 2017. Applications of RNA-Seq and Omics Strategies - From Microorganisms to Human Health. Applications of RNA-Seq and Omics Strategies - From Microorganisms to Human Health.
Peng Zhu, An-Qin Duan, Ting-Xian Deng, Xing-Rong Lu, Xiao-Ya Ma, Sha-Sha Liang, Chun-Ying Pang & Xian-Wei Liang. (2017) Generation of buffalo mammary epithelial cells with targeted knockout of 18s rDNA by a CRISPR/Cas9 adenovirus system. Biotechnology and Bioprocess Engineering 22:5, pages 569-576.
Crossref
Jeff Sekelsky. (2017) DNA Repair in Drosophila : Mutagens, Models, and Missing Genes . Genetics 205:2, pages 471-490.
Crossref